![Thomas DiRaimondo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas DiRaimondo
Directeur Technique/Scientifique/R&D chez
JANUX THERAPEUTICS, INC.
Fortune : 2 M $ au 31/07/2026
Profil
Thomas DiRaimondo is the founder of Sitari Pharma, Inc., founded in 2013.
Dr. DiRaimondo currently holds the position of Chief Scientific Officer at Janux Therapeutics, Inc., starting in 2024.
Education history includes a doctorate from Stanford University and undergraduate and graduate degrees from the University of Michigan.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/02/2026 | 106 425 ( 0,18% ) | 2 M $ | 31/07/2026 |
Postes actifs de Thomas DiRaimondo
| Sociétés | Poste | Début |
|---|---|---|
| JANUX THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/05/2018 |
Anciens postes connus de Thomas DiRaimondo
| Sociétés | Poste | Fin |
|---|---|---|
Sitari Pharma, Inc.
 Sitari Pharma, Inc. BiotechnologyHealth Technology Provides pharmaceutical research and development services | Fondateur | 01/08/2019 |
Formation de Thomas DiRaimondo
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
29
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sitari Pharma, Inc.
Sitari Pharma, Inc. BiotechnologyHealth Technology Provides pharmaceutical research and development services | Health Technology |
Janux Therapeutics, Inc.
 Janux Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops precision engineered immunotherapies | Health Technology |
